- Home
- Drug And Medication Industry
- Pain Therapeutics Market and Forecasts, May 2013
Industries
- Drug and Medication (258)
- Pathology (204)
- Skin Care Products (51)
- Pharmaceutical (36)
- Drug Discovery and Development (25)
-
- Biotechnology (17)
- Managed Care (15)
- Agriculture (14)
- Diagnostics (14)
- Medical Facility (14)
- Biological Therapy (13)
- General Medicine and Specialty Medicine (12)
- Biopharmaceutical (10)
- Energy & Environment (10)
- Fruit and Vegetable (10)
- Genomics (10)
- Chemical and Material (9)
- Drug Delivery Technology (9)
- Fish and Seafood (9)
- Tourism and Leisure (9)
Top countries
Publication dates
All regions
-
- Austria (2)
- Czech Republic (3)
- Denmark (3)
- Finland (1)
- France (8)
- Germany (10)
- Greece (1)
- Hungary (1)
- Ireland (70)
- Italy (6)
- Lithuania (1)
- Netherlands (4)
- Norway (2)
- Poland (4)
- Russian Federation (5)
- Slovakia (slovak Republic) (1)
- Slovenia (1)
- Spain (6)
- Sweden (1)
- Switzerland (8)
- United Kingdom (31)
-
- Australia (28)
- Austria (2)
- Canada (39)
- Czech Republic (3)
- Denmark (3)
- Finland (1)
- France (8)
- Germany (10)
- Greece (1)
- Hungary (1)
- Ireland (70)
- Israel (4)
- Italy (6)
- Japan (20)
- Mexico (3)
- Netherlands (4)
- New Zealand (2)
- Norway (2)
- Poland (4)
- Slovenia (1)
- South Korea (4)
- Spain (6)
- Sweden (1)
- Switzerland (8)
- Turkey (1)
- United Kingdom (31)
- United States (323)
data types
- All
- Company Data (2 066)
- Industry Data
- Country Data (362)
Pain Therapeutics Market and Forecasts, May 2013
You might be interested in: oxycodone, clinical trial
industry reports
country reports
Drug and Medication Sector
- Industry report
- February 2012
- 50 pages
... therapeutic options, such as bone metastatic pain or interstitial cystitis Patients on oral soc, but still in significant pain Specific type of pain-related symptom, such as allodynia, entrapment ...
- Industries: Drug and Medication
Drug and Medication in The United States : Innovation and Technology Trends
- Industry report
- March 2012
- 29 pages
... And center for human experimental therapeutics university of rochester school of medicine and dentistry more than 100 million americans have pain that persists for weeks to years. The total ...
- Industries: Drug and Medication
- Countries: United States
U.S. Pharmaceutical Business
- Industry report
- January 2012
- 30 pages
... Designed to target chronic pain market with novel opioid: Slow rate of entry into cns designed to: Reduce abuse liability Reduce drowsiness Reduce respiratory depression Long ...
- Industries: Pathology
- Countries: United States
Global Therapeutics Market Trends
- Industry report
- January 2011
- 9 pages
... Roche, amylin, novo-nordisk, ipsen and others. While cmos major players profiled are bachem, lonza, peptisyntha, polypeptide group and others. Peptide therapeutics market, by applications cancer ...
U.S. Opioid Industry Analysis
- Industry report
- May 2012
- 62 pages
... Francisco Use and misuse of opioid analgesics in high risk cohort Pcp attitudes Pcp ability to estimate misuse Conclusions what is chronic non-cancer pain pain that lasts longer than 3 ...
- Industries: Drug and Medication
- Countries: United States
U.S. Pharmaceutical Industry : Innovation and Technology Trends
- Industry report
- July 2011
- 19 pages
... Market potential therapeutic opportunity Increase in personalized medicine and targeted treatments Need for new diagnostic tools to identify patients most likely to respond to certain therapies 18 ...
- Industries: Pathology
- Countries: United States
Pharmaceutical Market in The United States
- Industry report
- January 2012
- 27 pages
... Direct early access to our r&d cardiovascular/ gastrointestinal oncology respiratory and inflammation cns and pain infectionnew opportunities science and technology phc and biomarkers em & ...
- Industries: Pathology
- Countries: United States, World
U.S. Pharmaceutical Business
- Industry report
- March 2013
- 26 pages
... Looking statements as a result of new information or otherwise. 3 Nektar therapeutics: well-positioned to achieve positive cash flow development pipeline in phase 2 in phase 1 preparing for clinic ...
- Industries: Pathology
- Countries: United States
U.S. Veterinary Healthcare Industry Brief
- Industry report
- March 2012
- 3 pages
... Spinout company glycobac llc have signed an agreement to commercialize research using genetically engineered insect cells for manufacturing vaccines, diagnostics or therapeutics for use in human ...
- Industries: Veterinary Healthcare
- Countries: United States
Drug and Medication in The United States : Innovation and Technology Trends
- Industry report
- June 2012
- 25 pages
- by Corporation
... On ambulation square4 no rescue medication allowed square4 primary endpoint: percentage of patients rating the method of pain control as Good And Excellent Over 48 hours square4 study evaluating 95 ...
- Industries: Drug and Medication
- Countries: United States
» Read our Company Profiles
3 Companies for Pain TherapeuticsReportlinker.com © Copyright 2013. All rights reserved.
